Name: Latest research reports of Cipla Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1502.8000 -51.80 (-3.33%)

NSE Aug 01, 2025 15:31 PM

Volume: 2.1M

Cipla Ltd.

31 Oct 2024

1502.80

-3.33%

Cipla (HOLD): Conditional launch of gAbraxane likely in FY25

Hold: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Goa plant receiving VAI likely to speed up gAbraxane launch in FY25E. In its 2QFY25 earnings call CIPLA said this would be delayed to H1FY27

Cipla Ltd. is trading above its 200 day SMA of 1488.8